Infectious Diseases
- A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects
Physicians should be vigilant and open-minded regarding possible adverse reactions to the vaccines, and should take time to discuss the demonstrated efficacy of vaccines with patients.
- COVID-19 vaccine-induced cellulitis and myositis
The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.
- Exanthem and enanthem with fever and dyspnea
The patient presented with high fever, productive cough, dyspnea, generalized myalgias, conjunctivitis, and whitish elevations with an erythematous base on the buccal mucosa.
- Neuropsychiatric assessment and management of the ICU survivor
Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.
- Another influenza season in the shadow of the COVID-19 pandemic
Flu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.
- Revisiting the ‘great masquerader’
An HIV patient presents with scaly brown lesions on the palms and soles, mildly painful oral erosions, and a buzzing sound in the right ear for the past 20 days.
- Fungus among us: A poster child for diagnostic stewardship
When interpreting the significance of Aspergillus species in respiratory culture, first ask if the culture was clinically indicated, or if this was an incidental finding.
- Is Aspergillus isolated from respiratory cultures clinically significant?
Aspergillus is ubiquitous, so the significance of the finding depends on the patient’s symptoms, underlying lung condition, immune status, and radiologic fi ndings.
- Risk-based guidelines: Redefining management of abnormal cervical cancer screening results
A shift from results-based to risk-based management, based on the patient’s immediate and 5-year risks of grade 3 or higher cervical intraepithelial neoplasia.
- Rapid cognitive decline and myoclonus in a 52-year-old woman
Symptoms also included confusion, blank staring, blurred vision, incoordination of the extremities, decreased verbal communication, and holding her left hand in a fist.